Molecular Breast Imaging (MBI) is emerging as a valuable supplemental screening tool for women with dense breasts, according to findings from the Density MATTERS trial published in Radiology. The study, along with an accompanying editorial, highlights MBI’s potential to improve breast cancer detection in this challenging patient population.

The Challenge of Dense Breasts

Dense breast tissue is common, affecting approximately 40% of women undergoing mammography. The National Cancer Institute explains that dense breasts have more fibrous and glandular tissue and less fatty tissue.this density can make it harder to detect tumors on a standard mammogram, increasing the risk of delayed diagnosis.

Density MATTERS Trial Results

the Density MATTERS trial evaluated the use of MBI in addition to digital breast tomosynthesis (DBT) – also known as 3D mammography – for women with dense breasts. In the first screening round, 7 of 10 cancers were only detected by MBI, demonstrating it’s ability to identify cancers missed by DBT alone. The trial involved[[Number of participants not provided in source text, needs further research]women with dense breasts.

How Molecular Breast Imaging Works

MBI utilizes a small amount of a radioactive tracer, technetium-99m sestamibi, which is absorbed by cancerous cells at a higher rate than normal tissue. A gamma camera then detects the tracer, creating an image that highlights areas of increased metabolic activity, potentially indicating the presence of cancer. According to Dr. Hruska, MBI is considered safe for routine screening, is well-tolerated by patients and is relatively inexpensive.

“MBI uses a well-established radiotracer that’s been used in cardiac imaging for a really long time,” Dr. Hruska said. “It has fewer risks than othre modalities and no contrast reactions. If a woman has a choice of modalities, it’s vital that she understands the benefits and risks of each and be involved in the decision-making.”

Benefits and Risks of MBI

Compared to other imaging techniques like MRI, MBI offers several advantages:

• Safety: The radiotracer used in MBI has a long history of safe use.
• Tolerance: Patients generally tolerate MBI well.
• Cost: MBI is relatively inexpensive compared to MRI.
• No Contrast Reactions: Unlike some imaging methods, MBI does not require contrast agents, eliminating the risk of allergic reactions.

However, MBI does involve exposure to a small amount of radiation. The benefits and risks should be discussed with a healthcare professional to determine the most appropriate screening strategy.

The Role of Digital Breast Tomosynthesis

Digital breast Tomosynthesis (DBT) remains a crucial component of breast cancer screening. DBT creates a three-dimensional image of the breast, improving cancer detection rates and reducing false positives compared to traditional 2D mammography. The Density MATTERS trial used DBT as the primary screening modality, with MBI serving as a supplemental tool.